Taylor Weiskittel, Austin Koukol, Caroline Kellinger, Andrey Ugolkov, Christopher Seifarth, Hu Li, Devalingam Mahalingam, Leiqing Zhang, Benedito A. Carneiro, Wafik S. El-Deiry, Andrew Paul Mazar. "Machine learning and statistical prediction of overall survival (OS) from pre-dose plasma biomarkers in a randomized phase 2 trial (1801 Part 3B) of the GSK-3 inhibitor elraglusib in metastatic pancreatic ductal adenocarcinoma (mPDAC): Application toward patient enrichment.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4185